Literature DB >> 18348289

Integrated DNA, cDNA, and protein studies in Becker muscular dystrophy show high exception to the reading frame rule.

Akanchha Kesari1, Laura N Pirra, Lakshmi Bremadesam, Orinthal McIntyre, Erynn Gordon, Alberto L Dubrovsky, V Viswanathan, Eric P Hoffman.   

Abstract

Becker muscular dystrophy (BMD) is a milder form of X-linked Duchenne muscular dystrophy (DMD). Here, we report a study of 75 patients with immunoblot and/or immunostaining findings of muscle biopsy consistent with BMD (abnormal dystrophin). We utilized multiplex ligation dependent probe amplification (MLPA) on genomic DNA (gDNA) to screen all 79 exons for both deletions and duplications. A total of 19 patients testing negative for MLPA mutations were tested for mRNA splicing abnormalities using cDNA-MLPA on muscle biopsy. Complete cDNA sequencing was done on MLPA-negative patients. We identified disease-causing mutations in 66 (88%) of the patients. Of the mutation-positive patients, 42 (64%) showed deletions of one or more exons, 14 (21%) showed duplications, and 10 (15%) showed various mutations detected by cDNA-MLPA and sequencing studies. We found a high rate of "exceptions" to the reading frame rule in this BMD series (out-of-frame BMD; 17/56 deletions/duplications; 30%). This was partly explained by the high incidence of 5' gene deletions in BMD patients (a region known to be a hotspot for exceptions), and due to complex splicing patterns in which a subset of transcripts showed deletions larger than gDNA (exon-skipping). Comparing our findings in BMD to previously published DMD data, BMD patients have higher proportions of duplications, a different distribution of mutations, and higher exception to the reading frame rule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348289     DOI: 10.1002/humu.20722

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

1.  Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies.

Authors:  Yingyin Liang; Songlin Chen; Jianzong Zhu; Xiangxue Zhou; Chen Yang; Lu Yao; Cheng Zhang
Journal:  Bosn J Basic Med Sci       Date:  2015-05-20       Impact factor: 3.363

2.  Dystrophinopathy muscle biopsies in the genetic testing ERA: One center's data.

Authors:  Courtney R Carlson; Steven A Moore; Katherine D Mathews
Journal:  Muscle Nerve       Date:  2018-01-24       Impact factor: 3.217

Review 3.  Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.

Authors:  Eric P Hoffman; Abby Bronson; Arthur A Levin; Shin'ichi Takeda; Toshifumi Yokota; Andreas R Baudy; Edward M Connor
Journal:  Am J Pathol       Date:  2011-05-23       Impact factor: 4.307

4.  Clinical Utility Gene Card for: Becker muscular dystrophy.

Authors:  David Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-02-21       Impact factor: 4.246

5.  Small mutations in Duchenne/Becker muscular dystrophy in 164 unrelated Polish patients.

Authors:  Janusz G Zimowski; Joanna Purzycka; Magdalena Pawelec; Katarzyna Ozdarska; Jacek Zaremba
Journal:  J Appl Genet       Date:  2021-01-09       Impact factor: 3.240

6.  Somatic mosaicism due to a reversion variant causing hemi-atrophy: a novel variant of dystrophinopathy.

Authors:  Jaya Punetha; Simin Mansoor; Tulio E Bertorini; Akanchha Kesari; Kristy J Brown; Eric P Hoffman
Journal:  Eur J Hum Genet       Date:  2016-03-09       Impact factor: 4.246

Review 7.  A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground.

Authors:  Toshifumi Yokota; Shin'ichi Takeda; Qi-Long Lu; Terence A Partridge; Akinori Nakamura; Eric P Hoffman
Journal:  Arch Neurol       Date:  2009-01

8.  Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.

Authors:  Dejia Li; Chun Long; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2009-01-08       Impact factor: 6.150

9.  Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report.

Authors:  Seth E Wakefield; Elliot L Dimberg; Steven A Moore; Brian S Tseng
Journal:  J Med Case Rep       Date:  2009-07-24

10.  Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms.

Authors:  Akanchha Kesari; Robert Neel; Lynne Wagoner; Brennan Harmon; Christopher Spurney; Eric P Hoffman
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.